247 related articles for article (PubMed ID: 26724790)
1. Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism.
Rubin MR; Zwahlen A; Dempster DW; Zhou H; Cusano NE; Zhang C; Müller R; Bilezikian JP
J Bone Miner Res; 2016 May; 31(5):1082-8. PubMed ID: 26724790
[TBL] [Abstract][Full Text] [Related]
2. Bone imaging in hypoparathyroidism.
Silva BC; Rubin MR; Cusano NE; Bilezikian JP
Osteoporos Int; 2017 Feb; 28(2):463-471. PubMed ID: 27577725
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.
Rubin MR; Zhou H; Cusano NE; Majeed R; Omeragic B; Gomez M; Nickolas TL; Dempster DW; Bilezikian JP
J Bone Miner Res; 2018 Nov; 33(11):1931-1939. PubMed ID: 29972871
[TBL] [Abstract][Full Text] [Related]
4. Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture.
Hong AR; Lee JH; Kim JH; Kim SW; Shin CS
Calcif Tissue Int; 2019 Apr; 104(4):382-389. PubMed ID: 30659307
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.
Cipriani C; Pepe J; Silva BC; Rubin MR; Cusano NE; McMahon DJ; Nieddu L; Angelozzi M; Biamonte F; Diacinti D; Hans D; Minisola S; Bilezikian JP
J Bone Miner Res; 2018 Dec; 33(12):2132-2139. PubMed ID: 30088838
[TBL] [Abstract][Full Text] [Related]
6. Three dimensional cancellous bone structure in hypoparathyroidism.
Rubin MR; Dempster DW; Kohler T; Stauber M; Zhou H; Shane E; Nickolas T; Stein E; Sliney J; Silverberg SJ; Bilezikian JP; Müller R
Bone; 2010 Jan; 46(1):190-5. PubMed ID: 19782782
[TBL] [Abstract][Full Text] [Related]
7. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.
Cipriani C; Abraham A; Silva BC; Cusano NE; Rubin MR; McMahon DJ; Zhang C; Hans D; Silverberg SJ; Bilezikian JP
Endocrine; 2017 Feb; 55(2):591-598. PubMed ID: 27757772
[TBL] [Abstract][Full Text] [Related]
8. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
9. Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study.
Sikjaer T; Rejnmark L; Thomsen JS; Tietze A; Brüel A; Andersen G; Mosekilde L
J Bone Miner Res; 2012 Apr; 27(4):781-8. PubMed ID: 22161686
[TBL] [Abstract][Full Text] [Related]
10. PTH and bone material strength in hypoparathyroidism as measured by impact microindentation.
Starr JR; Tabacco G; Majeed R; Omeragic B; Bandeira L; Rubin MR
Osteoporos Int; 2020 Feb; 31(2):327-333. PubMed ID: 31720712
[TBL] [Abstract][Full Text] [Related]
11. The Clinical and Skeletal Effects of Long-Term Therapy of Hypoparathyroidism With rhPTH(1-84).
Agarwal S; McMahon DJ; Chen J; Brossfield AV; Fernando J; Bilezikian JP; Cusano NE; Rubin MR
J Bone Miner Res; 2023 Apr; 38(4):480-492. PubMed ID: 36726204
[TBL] [Abstract][Full Text] [Related]
12. Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma.
Iglesias SG; Dominguez MLM; Herrero EF; Martinez-Pueyo JI; Arroba CM; Diaz-Guerra GM; Hawkins Carranza F
Surgery; 2019 Apr; 165(4):814-819. PubMed ID: 30554726
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
14. PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.
Misof BM; Roschger P; Dempster DW; Zhou H; Bilezikian JP; Klaushofer K; Rubin MR
J Bone Miner Res; 2016 Jan; 31(1):180-9. PubMed ID: 26111772
[TBL] [Abstract][Full Text] [Related]
15. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.
Gafni RI; Brahim JS; Andreopoulou P; Bhattacharyya N; Kelly MH; Brillante BA; Reynolds JC; Zhou H; Dempster DW; Collins MT
J Bone Miner Res; 2012 Aug; 27(8):1811-20. PubMed ID: 22492501
[TBL] [Abstract][Full Text] [Related]
16. Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).
Chen KS; Gosmanova EO; Curhan GC; Ketteler M; Rubin M; Swallow E; Zhao J; Wang J; Sherry N; Krasner A; Bilezikian JP
J Clin Endocrinol Metab; 2020 Oct; 105(10):e3557-65. PubMed ID: 32738041
[TBL] [Abstract][Full Text] [Related]
17. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
18. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
